Coverage check / Medicare
Medicare has separate programs to check.
Are you asking about a drug for weight loss, or for another illness or health problem? That helps you decide which payment program to ask about.
Begin with what the medicine treats
Part D is Medicare insurance that helps pay for prescription medicines.
The body uses a chemical message called GLP-1 to help control blood sugar and hunger. Some weight medicines copy its effects.
On September 26, 2026, medicines taken for weight loss remained outside ordinary Part D coverage.
At that date, some of the same medicines could qualify for other accepted uses, but the plan still had to approve coverage.
Regular drug coverage and a temporary payment program
Ordinary drug coverage
Ask the plan about the exact medicine and the condition being treated. Ask what records it needs and what you would pay.
Temporary help paying for weight medicines
Medicare’s temporary GLP-1 Bridge program helps pay for certain weight medicines. As of September 26, 2026, people who met its rules paid $50 for a monthly supply.
The program’s published start and end dates were July 1, 2026 and December 31, 2027. It paid separately from regular Part D drug coverage.
The temporary Bridge program did not change the rule that regular Part D excludes medicines taken for weight loss.
Who can use the Bridge?
A person’s Medicare plan, age, weight and health problems determined Bridge eligibility as of September 26, 2026. A prescription and approval before payment were required.
At that date, having type 2 diabetes ruled out use of the Bridge. They needed to ask their regular Part D drug plan about coverage instead.
Receiving a GLP-1 medicine under Part D during 2026 meant a member could not use the Bridge that year.
Approval before payment means the program accepts the request first. Ask the doctor or other person writing your prescription to check all the program’s rules against your plan and health history.
As of September 26, 2026, the Bridge list included semaglutide (Wegovy) tablets and injections, and orforglipron (Foundayo) tablets.
As of September 26, 2026, the Bridge paid for tirzepatide (Zepbound) only in the device called KwikPen. It did not pay for the pens or small bottles made to hold a single dose.
Read the medicine’s name and the name of its pen or bottle to the person checking coverage. For Zepbound, ask specifically whether it is the KwikPen.
What does the Bridge payment count toward?
On September 26, 2026, paying the Bridge’s $50 charge added nothing to either the Part D deductible or the yearly limit on your own costs for covered prescriptions.
A deductible is what you pay before your plan starts paying. The yearly limit is on your own covered drug costs, not on the amount the plan pays.
At that date, the Bridge gave no extra help paying to people with low incomes. Coupons could not lower its payment.